These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 14452492)
1. [Recollection of the first heparin era]. JORPES E Chemotherapia (Basel); 1961; 3():321-7. PubMed ID: 14452492 [No Abstract] [Full Text] [Related]
2. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors. Bangalore S; Toklu B; Kotwal A; Volodarskiy A; Sharma S; Kirtane AJ; Feit F BMJ; 2014 Nov; 349():g6419. PubMed ID: 25389143 [TBL] [Abstract][Full Text] [Related]
3. Is heparin still necessary after primary angioplasty in the era of platelet glycoprotein IIb/IIIa receptor inhibitors? A review of the literature. Lettieri C; De Servi S; Buffoli F; Aroldi M; Baccaglioni N; Romano M; Tomasi L; Izzo A; Zanini R J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):653-9. PubMed ID: 16932077 [TBL] [Abstract][Full Text] [Related]
5. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use. Kini AS; Rafael OC; Sarkar K; Rajdev S; Jakkula M; Mares AM; Kaplish D; Krishnan P; Kim MC; Sharma SK Catheter Cardiovasc Interv; 2009 Nov; 74(5):700-7. PubMed ID: 19496119 [TBL] [Abstract][Full Text] [Related]
6. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy? Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of low-dose unfractionated heparin during percutaneous coronary revascularisation and the relationship between activated clotting time and haemorrhagic or ischaemic complications: our results. Capuano C; Sesana M; Leonzi O; Cuccia C J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):866-71. PubMed ID: 17122672 [TBL] [Abstract][Full Text] [Related]
8. The story of the discovery of heparin and warfarin. Wardrop D; Keeling D Br J Haematol; 2008 Jun; 141(6):757-63. PubMed ID: 18355382 [TBL] [Abstract][Full Text] [Related]
9. Cut down on hospital stays, heparin use: treating AMI in the thrombolytic era. Phillips L Hosp Technol Ser; 1996 Apr; 15(5):6. PubMed ID: 10158287 [No Abstract] [Full Text] [Related]
10. Unfractionated heparin use after percutaneous coronary intervention: results of a trial with a vascular ultrasound endpoint. Juergens CP; Crozier JA; Robinson JT; Lo S; French JK; Leung DY Heart Lung Circ; 2008 Apr; 17(2):107-13. PubMed ID: 17913583 [TBL] [Abstract][Full Text] [Related]
11. Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial. Winningham MJ; Haussen DC; Nogueira RG; Liebeskind DS; Smith WS; Lutsep HL; Jovin TG; Xiang B; Nahab F J Neurointerv Surg; 2018 Jul; 10(7):611-614. PubMed ID: 29089415 [TBL] [Abstract][Full Text] [Related]
12. Heparin Versus Bivalirudin in Contemporary Percutaneous Coronary Intervention: A Welcome Back to an Old Friend Unfractionated Heparin. Centurión OA Crit Pathw Cardiol; 2015 Jun; 14(2):62-6. PubMed ID: 26102015 [TBL] [Abstract][Full Text] [Related]
13. Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry. Hibbert B; MacDougall A; Labinaz M; O'Brien ER; So DY; Dick A; Glover C; Froeschl M; Marquis JF; Wells GA; Blondeau M; Le May MR Circ Cardiovasc Interv; 2012 Dec; 5(6):805-12. PubMed ID: 23149331 [TBL] [Abstract][Full Text] [Related]
14. Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 Trial. Ducrocq G; Jolly S; Mehta SR; Rao SV; Patel T; Moreno R; Gao P; Steg PG Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25873729 [TBL] [Abstract][Full Text] [Related]
15. Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial. Pellaton C; Cayla G; Silvain J; Zeymer U; Cohen M; Goldstein P; Huber K; Pollack C; Kerneis M; Collet JP; Vicaut E; Montalescot G; Am Heart J; 2015 Oct; 170(4):778-86. PubMed ID: 26386802 [TBL] [Abstract][Full Text] [Related]
16. [Inflammatory patches at the point of injection of calcium heparin reflecting eczema caused by heparin: first case of an unrecorded side effect of heparin therapy]. Guillet G; Plantin P; Delaire P Presse Med; 1988 Jun; 17(22):1154-5. PubMed ID: 2969539 [No Abstract] [Full Text] [Related]
19. An active fraction of unfractionated heparin from a natural source is recognized by the first component of the complement system. Calabrese GC; Leocatanieto F; Recondo EF; Fernandez de Recondo ME Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL119-23. PubMed ID: 11936856 [TBL] [Abstract][Full Text] [Related]
20. The Second International Standard for heparin. BANGHAM DR; MUSSETT MV Bull World Health Organ; 1959; 20(6):1201-8. PubMed ID: 13796435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]